Lopez, Bb Girl .
HRN: 25-76-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/29/2024
09/05/2024
IV
50mG
Q24h
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes